echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Preventing stroke?

    Neurology: Preventing stroke?

    • Last Update: 2021-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Stroke , commonly known as "stroke", it is the second largest cause of death, behind medsci.


    Stroke , commonly known as "stroke", it is the second largest cause of death, behind medsci.


    China is the country with the highest burden of stroke in the world, with a lifetime risk as high as 39.


    According to the latest "China Stroke Report 2019" issued by the Chinese Stroke Society and the Chinese Center for Disease Control and Prevention , in 2018 alone, the number of deaths due to stroke in China was 1.


    Prevention In 2018 alone, the number of deaths due to stroke in China was 1.


    In the past few decades, with the continuous acceleration of social aging and urbanization, the prevalence of residents' unhealthy life>The incidence of stroke in my country continues to increase, and the burden of disease is showing an "explosive increase" trend.


    The burden of stroke disease in different countries/regions around the world.


    The burden of stroke disease in different countries/regions around the world.


    The study included patients with suspected stroke admitted within 4.


    immunity

    Endostatin is the tumor angiogenesis inhibitor with the strongest effect and the best experimental effect.


    Endostatin is the tumor angiogenesis inhibitor with the strongest effect and the best experimental effect.


    The best biomarker combination for identifying AIS is RBP-4+NT-proBNP, which can identify 29.


    Furthermore, in the subgroup of patients whose GFAP was measured by a high-sensitivity detection method, RBP-4, NT-proBNP and GFAP can identify 51.


    RBP-4, NT-proBNP and GFAP can identify 51.


    Biomarkers including RBP-4, NT-proBNP and GFAP have a specificity of 100% for the diagnosis of ischemic stroke, and they have a certain sensitivity.


    references:

    neurology.


    neurology.
    org/content/96/15/e1928" target="_blank" rel="noopener">Blood Biomarkers to Differentiate Ischemic and Hemorrhagic Strokes.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.